A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Aprobarbital
Allylestrenol
Allylestrenol may decrease the anticoagulant activities of Edoxaban.
Aprobarbital
Drospirenone
Drospirenone may decrease the anticoagulant activities of Edoxaban.
Aprobarbital
Ormeloxifene
The therapeutic efficacy of Edoxaban can be decreased when used in combination with Ormeloxifene.
Aprobarbital
Gossypol
The therapeutic efficacy of Edoxaban can be decreased when used in combination with Gossypol.
Aprobarbital
Triptolide
The therapeutic efficacy of Edoxaban can be decreased when used in combination with Triptolide.
Aprobarbital
Cloprostenol
The therapeutic efficacy of Edoxaban can be decreased when used in combination with Cloprostenol.
Aprobarbital
Isosorbide
The therapeutic efficacy of Edoxaban can be decreased when used in combination with Isosorbide.
Aprobarbital
Ulipristal
The therapeutic efficacy of Edoxaban can be decreased when used in combination with Ulipristal.
Aprobarbital
Lonidamine
The therapeutic efficacy of Edoxaban can be decreased when used in combination with Lonidamine.
Aprobarbital
Trestolone
The therapeutic efficacy of Edoxaban can be decreased when used in combination with Trestolone.
Aprobarbital
Octylphenoxy polyethoxyethanol
The therapeutic efficacy of Edoxaban can be decreased when used in combination with Octylphenoxy polyethoxyethanol.
Aprobarbital
p-Coumaric acid
The therapeutic efficacy of Edoxaban can be decreased when used in combination with p-Coumaric acid.
Aprobarbital
Potassium perchlorate
Edoxaban may increase the anticoagulant activities of Potassium perchlorate.
Aprobarbital
Benzylthiouracil
Benzylthiouracil may increase the anticoagulant activities of Edoxaban.
Aprobarbital
Methylthiouracil
Methylthiouracil may increase the anticoagulant activities of Edoxaban.
Aprobarbital
Dibromotyrosine
Dibromotyrosine may increase the anticoagulant activities of Edoxaban.
Aprobarbital
Potassium Iodide
Potassium Iodide may increase the anticoagulant activities of Edoxaban.
Aprobarbital
3,5-Diiodotyrosine
3,5-Diiodotyrosine may increase the anticoagulant activities of Edoxaban.
Aprobarbital
Limaprost
The risk or severity of adverse effects can be increased when Limaprost is combined with Edoxaban.
Aprobarbital
Omega-3 fatty acids
Omega-3 fatty acids may increase the anticoagulant activities of Edoxaban.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3